Issues in allogeneic HSCT: Therapeutic options for post-transplant relapse
Issues in allogeneic HSCT: Therapeutic options for post-transplant relapse
CNS involvement and prophylaxis in acute lymphoblastic leukaemia
Indications for allogeneic haematopoietic stem cell transplantation in adult acute lymphoblastic leukaemia
Metabolic vulnerability in NOTCH-driven T cell acute lymphoblastic leukaemia
MLL-rearranged acute lymphoblastic leukaemia
Updates on bispecific T cell engagers (BiTEs) for the treatment of acute lymphoblastic leukaemia
MRD management in adults with acute lymphoblastic leukaemia
Using CAR T cells for the treatment of acute lymphoblastic leukaemia
Optimal use of tyrosine kinase inhibitors as a treatment for Philadelphia chromosome-positive acute lymphoblastic leukaemia
Highlights from ICALL 2019
Precision diagnosis for tailored therapy in acute lymphoblastic leukaemia
Integrating, balancing and disregarding risk factors in paediatric acute lymphoblastic leukaemia